CANNABINOID RECEPTOR MEDIATING COMPOUNDS Read more about CANNABINOID RECEPTOR MEDIATING COMPOUNDS Germany13802153.0Filed on 2013-11-12
CANNABINOID RECEPTOR MEDIATING COMPOUNDS Read more about CANNABINOID RECEPTOR MEDIATING COMPOUNDS Switzerland13802153.0Filed on 2013-11-12
CANNABINOID RECEPTOR MEDIATING COMPOUNDS Read more about CANNABINOID RECEPTOR MEDIATING COMPOUNDS US Patent 11,485,709Filed on 2020-05-08
Synthesis Of The Monoester Of 1,3 Butandiol With A Trimer Of D-Beta-Hydroxybutayrate Using Lipase Catalysis In Nonaqueous Media And Modifications Of This And Other Esters Read more about Synthesis Of The Monoester Of 1,3 Butandiol With A Trimer Of D-Beta-Hydroxybutayrate Using Lipase Catalysis In Nonaqueous Media And Modifications Of This And Other Esters US Application 15/914,676Filed on 2018-03-07
PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS Read more about PYRAZOLE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MEDIATORS Australia2019227889Filed on 2019-09-10
GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Read more about GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS United Kingdom14818342.9Filed on 2014-06-24
GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Read more about GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS France14818342.9Filed on 2014-06-24
GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Read more about GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Germany14818342.9Filed on 2014-06-24
GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Read more about GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS Switzerland14818342.9Filed on 2014-06-24
CANNABINOID RECEPTOR MEDIATING COMPOUNDS Read more about CANNABINOID RECEPTOR MEDIATING COMPOUNDS US Application 16/438,850Filed on 2019-06-12